达安基因(002030) - 2025 Q2 - 季度业绩预告

Guangzhou Darui Biotechnology Co., Ltd. 2025 Semi-Annual Performance Forecast Current Period Performance Forecast The company anticipates a narrower net loss attributable to shareholders for H1 2025, ranging from 140 million to 200 million yuan, though non-recurring adjusted net loss is expected to widen 2025 Semi-Annual Performance Forecast | Item | Current Period | Prior Year Period | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders of Listed Company | Loss: 140.00 million – 200.00 million yuan | Loss: 399.22 million yuan | | Net Profit After Deducting Non-Recurring Gains and Losses | Loss: 220.00 million – 310.00 million yuan | Loss: 178.75 million yuan | | Basic Earnings Per Share | Loss: 0.10 – 0.14 yuan/share | Loss: 0.28 yuan/share | Communication with Accounting Firm The company explicitly states that this performance forecast has not been pre-audited by an accounting firm - This performance forecast has not been pre-audited by an accounting firm[4] Explanation of Performance Changes The overall net loss narrowed due to non-recurring gains from fair value increases in other non-current financial assets, while core business loss widened due to reduced revenue, increased credit impairment, and higher intangible asset amortization Reasons for Changes in Net Profit Attributable to Parent Net profit attributable to shareholders improved (loss narrowed) primarily due to an increase in the fair value of other non-current financial assets, recognized as non-recurring income - Net profit attributable to the parent increased compared to the prior year, primarily due to non-recurring gains from the fair value increase of other non-current financial assets[5] Reasons for Changes in Non-Recurring Adjusted Net Profit Non-recurring adjusted net profit declined (loss widened) due to reduced operating revenue from industry demand shifts and centralized procurement, increased credit impairment losses, and higher amortization of self-developed intangible assets - Non-recurring adjusted net profit decreased (loss widened) due to three main reasons: - Operating revenue decreased due to changes in industry demand and centralized procurement price adjustments[5] - Increased provision for credit impairment losses[6] - Increased amortization of self-developed intangible assets (registration certificates)[6] Other Relevant Information The company emphasizes that this performance forecast is a preliminary, unaudited result from the finance department, with final accurate data to be disclosed in the 2025 semi-annual report, urging investor caution - This performance forecast is a preliminary, unaudited result from the company's finance department, with specific financial data subject to the 2025 semi-annual report[7]